October 2, 2017, Vancouver, BC – The Board of Directors of LifeSciences BC announced at their Annual General Meeting, on September 26, that James P. Hatton Q.C. has stepped down as Chair. Nancy Harrison has been appointed as Chair of the LifeSciences BC Board of Directors effective immediately. Mr. Hatton served as Chair for two years and will remain on the Board of Directors.
Ms. Harrison is the former Co-founder and President of MSI Methylation Sciences, a private venture backed development company with a novel treatment of depression in a Phase II clinical trial. She was also a Partner and Senior Vice President of Ventures West Management Inc. Nancy spent 13 years with Ventures West leading its life sciences practice in Canada and the U.S. She is one of the most experienced life sciences investors in the Canadian venture capital industry and was instrumental in Ventures West’s involvement in the sector and with companies such as Angiotech Pharmaceuticals Inc., AnorMed Inc., Salmedix Inc. and Oncogenix Pharmaceuticals Inc. During her time with Ventures West, the firm grew from approximately $80 million to over $750 million. Nancy has a degree in Engineering from Queen’s University and an MBA from McGill University.
“We are indeed fortunate to have such a skilled and talented life science professional to steer our Board of Directors. Nancy is well respected and recognized as an invaluable influencer not only here in B.C., but across the country. We would also like to thank James Hatton for role as chair for the past two years” said Dr. Lesley Esford, President and CEO of LifeSciences BC.
The Chair also announced three new directors joining the LSBC Board of Directors: Mr. Scott Phillips, Founder & CEO of Starfish Medical, Dr. Pieter Cullis, Professor, Department of Biochemistry and Molecular Biology, Faculty of Medicine, UBC and Mr. Ali Ardakani, Founder and Managing Director, Novateur Ventures Inc.
For More Information Please Contact:
LifeSciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, LifeSciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.